Request Sample Inquiry
Cord Blood Stem Cells Market

Cord Blood Stem Cells Market

Cord Blood Stem Cells Market Global Industry Assessment & Forecast

# Pages:

136

Base Year:

2021

Nov - 2021

Format:

Report Code:

VMR-2021-0195

Segments Covered
  • By Type Allogeneic Stem Cell, Autologous Stem Cell
  • By Application Autoimmune Diseases, Immunodeficiencies, Malignancies, Caners, Solid Tumors, Others
Snapshot
Forecast YearsForecast Years: 2021 - 2028
Historical YearsHistorical Years: 2016 - 2020
Revenue 2021Revenue 2021: 1535 Million
Revenue 2028Revenue 2028: 4756 Million
Revenue CAGRRevenue CAGR (2021 - 2028): 5.3
Fastest Growing Region Fastest Growing Region (2022 - 2028) North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst

Key Insights

The global Cord Blood Stem Cells market was valued at USD 1535 Million in 2020 and is projected to reach USD 4756 Million by 2028, growing at a CAGR of 5.3% from 2021 to 2028.

Years Parameters
Historical Data (Actual Data) 2016-2020
Base Year Data 2020
Current Year Date 2021
Projected year data 2021-2028
Annual Market Size (2028) 4756 Million
Annual Market Size (2021)
CAGR (2021 - 2028) 5.3%

Overview and Description

After a baby is born, cord blood is left in the umbilical cord and placenta. It is relatively easy to collect, with no risk to the mother or baby. It contains hematopoietic (blood) stem cells: rare cells normally found in the bone marrow.


This report provides an analysis of the Cord Blood Stem Cells market for the historic period of 2016–2019 and forecasts for 2021–2028 while 2020 is considered as a base year for estimations. The report includes exhaustive analysis of segments, regions and countries comprising of market size and estimations in terms of revenue for the years 2016–2028. There regional section of the report is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, the report also covers exhaustive information on growth factors/drivers, restraints, opportunities, regulatory landscape and technology roadmap among others. Moreover, the report also includes exhaustive SWOT analysis, PEST analysis, value chain analysis, and Porter’s five forces analysis on Cord Blood Stem Cells market. This data is likely to help the industry stakeholders and stimulate the decision-making process.

Yearly Infographics 1535 Million 4756 Million

COVID-19 Impact Analysis

The COVID-19 outbreak has affected various industries worldwide. The Cord Blood Stem Cells market is no exception. Governments across the world took severe actions like border seals, lockdown, and implementing strict social distancing measures, in order to stop swift spread of COVID-19. These actions led to severe impact on the global economy. Industrialist across the globe were forced to halt their production, leading to supply chain disruptions and impairing of various industries. However, it is expected that reopening of trade activities, the market will witness steady growth in demand in the coming years. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends for all the regions and countries.


The report provides a completely separate chapter for COVID-19 Impact Analysis. This chapter includes:

o   Impact Assessment of COVID-19 Pandemic

o   Pre & Post COVID-19 Market Size

o   Qualitative analysis on the short term & long-term impact of COVID-19 on the market

o   The analysis provides foremost strategies adopted by competitors to minimize the impact of the pandemic on their business activities and scope for future developments.

Industry Analysis

Key driver for the market is that transplants of hematopoietic stem cells (HSCs) from cord blood can be used to treat several different blood diseases, such as leukemia. 

Stem cells can be used in treatments for many different types of diseases. One of the main places young stem cells are found is in cord blood, which can be stored at birth and saved for future use if needed. 

The increase in prices of advanced surgeries is expected to hamper the growth of the market in forecast period.

Global Cord Blood Stem Cells Market Report Scope

Parameter Details
Market Size Provided for Years 2016-2028
Base Year 2020
Historic Years 2016-2020
Forecast Years 2021-2028
Market Size Provided In Terms Of Revenue & Volume
Segments Covered Type, Application
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Countries Covered The U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, South East Asia, Brazil, Argentina, GCC Countries, and South Africa, among others
Companies Covered BioCell Pty. Ltd., Kaneka Corporation, DomaniCell LLC, Future Health Technologies, Eticur, Advanced Cell Technology Inc., Banco De Celulas Madre, J.P. McCarthy Cord Stem Cell Bank, CyGenics Ltd, AlphaCord.
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Market Segmentation

The report delivers an acute breakdown of the market based on various segments such as Type, Application, , and region. The report includes market size and forecast for each segment by region/country for the years 2016–2028. Moreover, it also covers a thorough analysis of growth factors and opportunities impacting segmental growth.

On the basis of Type, the market is divided into Allogeneic Stem Cell, Autologous Stem Cell. Allogeneic Stem Cell dominated the global Cord Blood Stem Cells market in 2020 and is projected to witness the same trend during the forecast period.

Based on Application, the market is segmented into Autoimmune Diseases, Immunodeficiencies, Malignancies,Caners, Solid Tumors, Others. Autoimmune Diseases accounted for the highest market share and is expected to grow at a significant CAGR from 2021 to 2028. 

Global Cord Blood Stem Cells Market: Type Segment Analysis

    • Allogeneic Stem Cell
    • Autologous Stem Cell

Global Cord Blood Stem Cells Market: Application Segment Analysis

    • Autoimmune Diseases
    • Immunodeficiencies
    • Malignancies
    • Caners
    • Solid Tumors
    • Others

Regional Analysis: Preview

Based on the geography, the global Cord Blood Stem Cells market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. Moreover, the regional sections if further bifurcated into key country level markets for better understanding of the market.

The report covers detailed analysis on drivers, business opportunities, regulatory norms, supplier concertation and such other factors impacting regional growth. Moreover, it also covers market estimations and forecast for each segment for each region for the years 2016–2028. 

Market Size, 2021 (USD Billion)
North America
Europe
Asia Pacific
South America
Middle East Africa

Global Cord Blood Stem Cells Market: Regional Analysis

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

The global Cord Blood Stem Cells market report provides an exhaustive competitive landscape to give a comprehensive synopsis of the global market. Major players in the Cord Blood Stem Cells market are BioCell Pty. Ltd., Kaneka Corporation, DomaniCell LLC, Future Health Technologies, Eticur, Advanced Cell Technology Inc., Banco De Celulas Madre, J.P. McCarthy Cord Stem Cell Bank, CyGenics Ltd, AlphaCord..  This section of the report provides in depth analysis on key market players based on various parameters such as business overview, portfolio analysis, business strategies, financial performance, geographical presence, and recent developments among others. It will also include information on key strategies adopted by major market players. 

Global Cord Blood Stem Cells Market: Key Highlights

  • The global Cord Blood Stem Cells market was valued at USD 1535 Million in 2020
  • The global Cord Blood Stem Cells Market is projected to reach USD 4756 Million by 2028
  • North America held the highest share of the Cord Blood Stem Cells market in 2020
  • Some of the major companies operating in the Cord Blood Stem Cells market are BioCell Pty. Ltd., Kaneka Corporation, DomaniCell LLC, Future Health Technologies, Eticur, Advanced Cell Technology Inc., Banco De Celulas Madre, J.P. McCarthy Cord Stem Cell Bank, CyGenics Ltd, AlphaCord.

FAQ
Frequently Asked Question
  • The global Cord Blood Stem Cells valued at 1535 Million in 2020 and is expected to reach 4756 Million in 2028 growing at a CAGR of 5.3%.

  • The prominent players in the market are BioCell Pty. Ltd., Kaneka Corporation, DomaniCell LLC, Future Health Technologies, Eticur, Advanced Cell Technology Inc., Banco De Celulas Madre, J.P. McCarthy Cord Stem Cell Bank, CyGenics Ltd, AlphaCord..

  • The market is project to grow at a CAGR of 5.3% between 2021 and 2028.

  • The driving factors of the Cord Blood Stem Cells include

    • Key driver for the market is that transplants of hematopoietic stem cells (HSCs) from cord blood can be used to treat several different blood diseases, such as leukemia.
    • Stem cells can be used in treatments for many different types of diseases. One of the main places young stem cells are found is in cord blood, which can be stored at birth and saved for future use if needed.

  • North America was the leading regional segment of the Cord Blood Stem Cells in 2020.